| RS386834120 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS386834121 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS386834122 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS386834123 |
CLN8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834124 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS386834125 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834126 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834128 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834130 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS386834131 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834132 |
CLN8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS386834133 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834134 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS386834135 |
CLN8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834138 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS386834139 |
CLN8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS386834140 |
TREM2
|
Health Risk |
Likely pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
| RS386834141 |
TREM2
|
Health Risk |
Pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
| RS386834142 |
TREM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
| RS386834143 |
TREM2
|
Health Risk |
Pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 |
| RS386834144 |
TREM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 |
| RS386834146 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile onset spinocerebellar ataxia, Infantile onset spinocerebellar ataxia |
| RS386834148 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS386834149 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 4 |
| RS386834150 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 4 |
| RS386834151 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS386834152 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS386834153 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 4 |
| RS386834155 |
CEP290
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 4 |
| RS386834156 |
CEP290
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 4 |
| RS386834157 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS386834158 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS386834159 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS386834160 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834161 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834162 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834163 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834164 |
AMN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834165 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834167 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834168 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome type 2, Imerslund-Grasbeck syndrome |
| RS386834169 |
AMN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 2 |
| RS386834170 |
AMN;CDC42BPB;LOC130056553
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome type 2, Imerslund-Grasbeck syndrome |
| RS386834171 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834172 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834173 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834174 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834175 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834176 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834177 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 1 |
| RS386834178 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834179 |
AMN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS386834180 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834181 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834182 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834183 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 3 |
| RS386834185 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel syndrome, type 3 |
| RS386834186 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834187 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834188 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834190 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834191 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834192 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 3 |
| RS386834193 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 3 |
| RS386834194 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel syndrome, type 3 |
| RS386834195 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834196 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834197 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834198 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834199 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834200 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834201 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel syndrome, type 3 |
| RS386834202 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834203 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel syndrome, type 3 |
| RS386834204 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834205 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel syndrome, type 3 |
| RS386834206 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834207 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834208 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS386834226 |
F5
|
Health Risk |
Pathogenic |
— |
| RS386834227 |
F5
|
Health Risk |
Pathogenic |
— |
| RS386834230 |
ALDH1A3
|
Health Risk |
Pathogenic |
— |
| RS386834233 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS386834234 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS386834235 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS386834236 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS386834239 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Early-onset retinal dystrophy |
| RS386834241 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS386834243 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Retinitis pigmentosa 94 |
| RS386834252 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis |
| RS386834253 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS386834260 |
RD3
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 12, Leber congenital amaurosis 12 |
| RS386834261 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Retinal dystrophy |
| RS386834263 |
CACNA1D
|
Health Risk |
Likely pathogenic |
— |
| RS386834264 |
CACNA1D
|
Health Risk |
Pathogenic |
Aldosterone-producing adenoma with seizures and neurological abnormalities, Aldosterone-producing adenoma with seizures and neurological abnormalities |
| RS387906217 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS387906218 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Senior-Loken syndrome 7 |
| RS387906219 |
TPRN
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 79, Autosomal recessive nonsyndromic hearing loss 79 |
| RS387906220 |
TPRN
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 79, Autosomal recessive nonsyndromic hearing loss 79 |
| RS387906221 |
TPRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 79, Rare genetic deafness |